000 01327 a2200397 4500
005 20250513233753.0
264 0 _c20010524
008 200105s 0 0 eng d
022 _a1041-6102
024 7 _a10.1017/s1041610200006633
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aNegrón, A E
245 0 0 _aRisperidone in the treatment of patients with Alzheimer's disease with negative symptoms.
_h[electronic resource]
260 _bInternational psychogeriatrics
_cDec 2000
300 _a527-36 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAffect
_xdrug effects
650 0 4 _aAged
650 0 4 _aAged, 80 and over
650 0 4 _aAlzheimer Disease
_xdrug therapy
650 0 4 _aAntipsychotic Agents
_xtherapeutic use
650 0 4 _aCognition
_xdrug effects
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMedical Records
650 0 4 _aMiddle Aged
650 0 4 _aOutpatients
650 0 4 _aPsychomotor Agitation
_xdrug therapy
650 0 4 _aRetrospective Studies
650 0 4 _aRisperidone
_xtherapeutic use
650 0 4 _aTreatment Outcome
700 1 _aReichman, W E
773 0 _tInternational psychogeriatrics
_gvol. 12
_gno. 4
_gp. 527-36
856 4 0 _uhttps://doi.org/10.1017/s1041610200006633
_zAvailable from publisher's website
999 _c11200057
_d11200057